SB
MDCO

Suntrust Banks’s Medicines Co MDCO Stock Holding History

Suntrust Banks’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-81,944
Closed -$3.16M – 1958
2013
Q4 		$3.16M Sell
81,944
-566
-0.7% -$20.2K 0.01% 546
2013
Q3 		$2.76M Sell
82,510
-716
-0.9% -$22.8K 0.01% 575
2013
Q2 		$2.56M Buy
+83,226
New +$2.78M 0.01% 556

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Suntrust Banks's MDCO Position: Q1 2014 in Review

Suntrust Banks sold out of Medicines Co (MDCO) in Q1 2014, closing a stake of 81,944 shares — an estimated $3.16M sold.

Suntrust Banks first reported a position in MDCO in Q2 2013 and held it in 3 quarters. The position peaked at $3.16M in Q4 2013. 166 funds tracked by Wall St. Rank hold MDCO as of Q1 2014.

  • Suntrust Banks reported no remaining Medicines Co position as of Q1 2014 after selling out during the quarter.
  • Suntrust Banks sold 81,944 Medicines Co shares in Q1 2014, an estimated $3.16M.
  • Suntrust Banks first reported a position in Medicines Co in Q2 2013 and held it in 3 quarters.
  • Suntrust Banks's Medicines Co position peaked at $3.16M in Q4 2013.
  • 166 funds tracked by Wall St. Rank held Medicines Co as of Q1 2014.

Based on Suntrust Banks's 13F filing for Q1 2014, filed 14 May 2014.